What does DOKTERS VANDEURZEN-GABRIELS do?

DOKTERS VANDEURZEN-GABRIELS is a specialist medical practice in Bree. Private Limited, started on 24 October 2003, 1 establishment.

What is the address of DOKTERS VANDEURZEN-GABRIELS?

The registered office of DOKTERS VANDEURZEN-GABRIELS is located at Kleine Genatteweg 16, 3960 Bree.

Is DOKTERS VANDEURZEN-GABRIELS still active?

Yes. According to the CBE (28 September 2026) DOKTERS VANDEURZEN-GABRIELS is active, legal situation “Normale toestand”, started on 24 October 2003.

Is DOKTERS VANDEURZEN-GABRIELS registered on Peppol?

Yes, DOKTERS VANDEURZEN-GABRIELS is registered on the Peppol network with ID 0208:0861289130.

What is the enterprise number of DOKTERS VANDEURZEN-GABRIELS?

The enterprise number of DOKTERS VANDEURZEN-GABRIELS is BE0861289130.

When was DOKTERS VANDEURZEN-GABRIELS founded?

DOKTERS VANDEURZEN-GABRIELS was founded on 24 October 2003.

Who are the directors of DOKTERS VANDEURZEN-GABRIELS?

According to the 2025 annual accounts, the directors of DOKTERS VANDEURZEN-GABRIELS are: Ingeborg Gabriëls, Kurt Vandeurzen.

Is DOKTERS VANDEURZEN-GABRIELS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 October 2003; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DOKTERS VANDEURZEN-GABRIELS make in 2025?

DOKTERS VANDEURZEN-GABRIELS posted a profit after taxes of € 322,778 in financial year 2025.

What is the revenue of DOKTERS VANDEURZEN-GABRIELS?

As a small company, DOKTERS VANDEURZEN-GABRIELS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 468,421.

DOKTERS VANDEURZEN-GABRIELS (Private Limited) - Bree

Dossier DOKTERS VANDEURZEN-GABRIELS, printed on 28 September 2026 from databakkes.be/en/0861289130/dokters-vandeurzen-gabriels. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DOKTERS VANDEURZEN-GABRIELS from Bree, company number BE0861289130, closed financial year 2025 with a result of € 322,778 after tax. For that financial year DOKTERS VANDEURZEN-GABRIELS recorded a gross margin of € 468,421 and equity of € 2.1 million. Compared with financial year 2024, the result moved from € 471,634 to € 322,778. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 27, 2026.

What it is worth Growing

€ 2.1 million

▲ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 322,778

▼ 32% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 667,992

▼ 7% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 238,905 paid out

74 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 29,517

▼ 37% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,422

▲ 257% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 52,509

▼ 14% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 448,017 Gross margin 2022: € 448,017 First fiscal year in the series	€ 421,128 Gross margin 2023: € 421,128 ▼ 6% vs 2022 (€ 448,017) Unfavourable step	€ 485,037 Gross margin 2024: € 485,037 ▲ 15% vs 2023 (€ 421,128) Favourable step	€ 468,421 Gross margin 2025: € 468,421 ▼ 3% vs 2024 (€ 485,037) Unfavourable step	▼ 3%
Profit after taxes	€ 315,527 Profit after taxes 2022: € 315,527 First fiscal year in the series	€ 296,347 Profit after taxes 2023: € 296,347 ▼ 6% vs 2022 (€ 315,527) Unfavourable step	€ 471,634 Profit after taxes 2024: € 471,634 ▲ 59% vs 2023 (€ 296,347) Favourable step	€ 322,778 Profit after taxes 2025: € 322,778 ▼ 32% vs 2024 (€ 471,634) Unfavourable step	▼ 32%
Equity	€ 1,373,191 Equity 2022: € 1,373,191 First fiscal year in the series	€ 1,635,242 Equity 2023: € 1,635,242 ▲ 19% vs 2022 (€ 1,373,191) Favourable step	€ 2,041,655 Equity 2024: € 2,041,655 ▲ 25% vs 2023 (€ 1,635,242) Favourable step	€ 2,125,528 Equity 2025: € 2,125,528 ▲ 4% vs 2024 (€ 2,041,655) Favourable step	▲ 4%
Total debts	€ 333,807 Total debts 2022: € 333,807 First fiscal year in the series	€ 98,278 Total debts 2023: € 98,278 ▼ 71% vs 2022 (€ 333,807) Favourable step	€ 129,206 Total debts 2024: € 129,206 ▲ 31% vs 2023 (€ 98,278) Unfavourable step	€ 59,868 Total debts 2025: € 59,868 ▼ 54% vs 2024 (€ 129,206) Favourable step	▼ 54%
Cash	€ 905,223 Cash 2022: € 905,223 First fiscal year in the series	€ 706,770 Cash 2023: € 706,770 ▼ 22% vs 2022 (€ 905,223) Unfavourable step	€ 714,609 Cash 2024: € 714,609 ▲ 1% vs 2023 (€ 706,770) Favourable step	€ 667,992 Cash 2025: € 667,992 ▼ 7% vs 2024 (€ 714,609) Unfavourable step	▼ 7%
Retained profit	€ 1,335,991 Retained profit 2022: € 1,335,991 First fiscal year in the series	€ 1,598,042 Retained profit 2023: € 1,598,042 ▲ 20% vs 2022 (€ 1,335,991) Favourable step	€ 2,004,455 Retained profit 2024: € 2,004,455 ▲ 25% vs 2023 (€ 1,598,042) Favourable step	€ 2,088,328 Retained profit 2025: € 2,088,328 ▲ 4% vs 2024 (€ 2,004,455) Favourable step	▲ 4%
Dividend	€ 171,157 Dividend 2022: € 171,157 First fiscal year in the series	€ 34,296 Dividend 2023: € 34,296 ▼ 80% vs 2022 (€ 171,157) Unchanged	€ 65,222 Dividend 2024: € 65,222 ▲ 90% vs 2023 (€ 34,296) Unchanged	€ 238,905 Dividend 2025: € 238,905 ▲ 266% vs 2024 (€ 65,222) Unchanged	▲ 266%
Balance sheet total	€ 1,706,998 Balance sheet total 2022: € 1,706,998 First fiscal year in the series	€ 1,733,521 Balance sheet total 2023: € 1,733,521 ▲ 2% vs 2022 (€ 1,706,998) Unchanged	€ 2,170,861 Balance sheet total 2024: € 2,170,861 ▲ 25% vs 2023 (€ 1,733,521) Unchanged	€ 2,185,396 Balance sheet total 2025: € 2,185,396 ▲ 1% vs 2024 (€ 2,170,861) Unchanged	▲ 1%

Key figures of DOKTERS VANDEURZEN-GABRIELS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DOKTERS VANDEURZEN-GABRIELS?

What happened at DOKTERS VANDEURZEN-GABRIELS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2029 Ingeborg Gabriëls stepped down as director. NBB
2029 Kurt Vandeurzen stepped down as director. NBB
Jul 27, 2026 New annual accounts for financial year 2025: profit of € 322,778 (▼ 32% vs 2024). Source: NBB ↗
2017 Ingeborg Gabriëls became a director. NBB
2017 Kurt Vandeurzen became a director. NBB
Oct 24, 2003 New establishment in Bree. KBO
Oct 24, 2003 Start of the company according to the CBE. KBO

In short

From € 315,527 profit in 2022 to € 322,778 profit in 2025.

Paid € 596,313 in corporate taxes since 2022.

Best year ever: 2024, with € 471,634 profit.

Paid out € 509,579 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DOKTERS VANDEURZEN-GABRIELS? We notify you, reason included.

Follow DOKTERS VANDEURZEN-GABRIELS

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Directors

According to the 2025 annual accounts

Ingeborg Gabriëls

Director

Also active at: IMMO CARE BONEPUT

since 2017 · until 2029

Kurt Vandeurzen

Director

Also active at: Associatie Inwendige Geneeskunde Maria Ziekenhuis Noord Limburg

since 2017 · until 2029

Establishments

Establishment units

Physical locations of this company

Registered office

Kleine Genatteweg 16

3960 Bree

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0861.289.130
VAT number: BE 0861.289.130
Registered office: Kleine Genatteweg 16, 3960 Bree
Names & denominations: DOKTERS VANDEURZEN-GABRIELS
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 24 October 2003
Peppol: Active · Active since 15 Apr 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗

DOKTERS VANDEURZEN-GABRIELS